Repros Therapeutics Inc (RPRX)

[corpstrat]

Clark, we're all sounding like broken records, i know, but you surely need to take account of the mkt cap and the potential value of Proellex in your invesment decision here.
Even if fears prove true on the anemia trial design - and I expect you know that BSR finds them overblown - it would be a delay of what is still a relatively near term commercialization.

Surely the reason there's not an enormous amount of DNDN-like probing of the trial design details is that walldiver and ocyan are not into UF. You and io are the main stat-oriented transfers here from DNDN IV and ihub, aren't you. Anyway, when push came to shove, did all that brilliant thinking lead to stronger predictions - and of what? I'm genuinely asking your recall and opinion. You may just be missing the intellectual stimulus rather than risk reduction through insight?

The bummer is that for whatever reason the negativity holds down the pps and makes funding challenging. It becomes a self-fulfilling FUD. You'll remember that DNDN was nearly caught in the same jam in the 2 years before the AC - though in their case they were spending unnecessarily on a big staff and overpaid CEO where RPRX is very strategic in its spending.